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Cis-regulatory elements in the long terminal repeat (LTR) of human foamy virus (HFV) were identified by using L TR 
mutants to transiently express the chforamphenicol acetyf-transferase gene after co-transfection with an expression 
plasmid for the virus bel-1 (transactivator) gene. The R~U5 region and an element in the 5' U3 region were found to 
negatively influence HFV geneexpress Ion. The complete BEL-1 responsive regionwas mapped to axtend from nucleo-
tide position -471 to position -93 relative to the start of transcription. Within this region, three e,ements were 
ldentified that in the homologaus or a heterologous (SV40) promoter context can, independently and irrespective of 
their orientation, act as targets for BEL-1. Theseelementsare located between nucleotide positions -4131-378, 
-3611-291, and -124/-93. The target elements do not share obvious sequence homologies. The mechanism of HFV 
transactivation appears to be novel among the complex retroviruses and is likely to involve, as yet, undiscovered 
cellular DNA binding factors. Iei f993 Acadernic Press, lnc. 
JNTRODUCTION 
Human foamy virus (HFV) belongs to the retroviruses 
which regulate their gene expression by a transacting 
activator of viral transcription (Cullen, 1991 ). The viral 
bel-1 gene has been identified to encode for a 36 k 
nuclear phosphoprotein that augments HFV lang termi-
nal repeat (LTR} directed transcription in a variety of 
mammalian and in avian cells (Rethwilm et al., 1991; 
Keller et al., 1991; Venkatesh et al., 1991, Venkatesh 
et al., 1993). Transcript mapping experiments revealed 
three mRNAs, two of which are multiply spliced, that 
may give rise to BEL-1 protein (Muranyi and FIOgel, 
1991 }. BEL-1 is the only regulatory HFV protein which 
is essential for virus repfication in vitro (Bau nach et af .. 
1993). No further activity than the transcriptionaJ ef-
fects of BEL-1 could be attributed to this protein (Baun-
ach et af.,. 1993). 
BEL-1 (or TAFHFV• for transactivator of foamy virus} 
acts on a U3 DNA elernent of the viral LTR (Rethwilm et 
al., 1991; Keller er al., 1991; Venkatesh et al., 1991 ). 
The foamy virus U3 regions are among the Iongest 
compared to other retroviruses; HFV U3 is 777 bp long, 
and the U3 regions of simian foamy virus (SFV) type 1 
and 3 are 1296 and 1332 bp in length, respectively 
(Mergia et al., 1 990; Renne et al., 1992). 
1 To whom correspondence and reprint requests shoufd be ad-
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Jn previous studies on the mapping of BEL-1 respon-
sive elements in HFV U3, the BEL-1 target regionwas 
located upstream of positions -94 (Keller et al., 1991) 
and -62 (Venkatesh et al., 1991) respectivery. relative 
to the start of transcription. A more definitive analysis 
has been performed on the TAF response region of 
SFV-1 and SFV-3. Two regions in the SFV~ 1 L TR be-
tween positions -1196 and -880 and between -403 
and -125 were identified to respond to TAFsFv- 1 ; the 
latter element was also found to act as an inducible 
enhancer in an orientation independent manner in the 
context of a heterologous promoter (Mergia et al., 
1992). ln the SFV-3 LTR, two regions (-637/-496 and 
-496/-180, respectively) that confer TAFsFv.3 respon-
siveness to a heterofogous promoter, irrespective of 
their orientation, have been mapped (Renne et al:, 
1993). HFV and SFV U3 regions are highly divergent 
compared to Rand U5 sequences (Renne et al., 1992). 
This is reflected by a low degree of HFV and SFV T AF 
amino acid homology compared to the env and pol 
proteins (Mergia et al .. 1991; Renne er a/., 1992). Thus, 
TAFsFv-1 does not stimulate the HFV L TR {Mergia et al., 
1992). Enhancement of SFV-3 L TR activity by TAFsFV-I 
has been described (Renne et al., 1993) which might 
reflect the cfoser relatedness of these two viruses 
(Renne et al., 1992). However, T AF sFv.3 does not stimu-
late reporter geneexpressiondriven by the SFV-1 LTR 
(Renne et al., .1993). 
While the results of these experiments suggest a 
highly specific mechanism of foamy virus transactiva-
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pHbel-ls 
FtG. 1. pHbel-1 s expression vector. which was co-transfected with 
the indicator plasmids ln all experiments. The bel-1 coding sequence 
was cloned as an Sspl fragment derived from plasmid pHSRV (Reth-
wilm et al., 1990) into the EcoR\ site in the third exon of the rabbit 
ß-globin gene of pKCR3 {O'Hare et al., 1981) in which the SV40 
promoterwas replaced by 'the mause M HC class I H-2Kb enhancer/ 
promoter {Kimura et al., 1986). lntron and polyadenylation se-
quences are indicated as bald lines. 
tion, TAFHFv and TAFsFv proteins were found to aug-
ment lentivirus L TR directed gene expression, which 
may also indicate some pleiotropic effects of toamy 
TAF proteins (Keller et af., 1991; Mergia et al., 1992}. 
The human immunodeficiency virus type 1 (HIV-1) U3 
element between positions -158/-118 was found to 
be essentiell for transactivation by T AFHFv (Lee et al., 
1992; Keller et al., 1992). Within this element is con-
tained a nonamer motif which shares eight out of nine 
nucleotides with an HFV U3 motif between positions 
-135/-127. This sequence has therefore been consid-
ered as the BEL-1 responsive element (BRE). 
Since knowledge of the TAF target site(s) in the HFV 
L TR is crucial in elucidating the mechanism of HFV 
specific transactivation, we constructed a series of 
. LTR mutants and assayed their responsiveness to 
BEL-1 in both homologaus and heterologous promoter 
contexts. Our results support the view that the mecha-
nism of foamy virus transactivation is novel among 
complex retroviruses. 
MATERIALSAND METHODS 
Plasmid constructions 
All DNA manipulations were done by established mo-
lecular cloning techniques (Sambrook et al., 1989). Re-
combinant plasmids were characterized by dideoxy 
sequencing (Sanger et a/., 1977). 
The BEL-1 expression plasmid, pHbel-1 s, was con-
structed by inserting the bel-1 coding sequence as an 
Sspl fragment derived from pHSRV (Rethwilm et al .• 
1990} into the EcoRI site of pH2EV after filling in with 
Klenow enzyme. pH2EV is a derivative of the pKCR 
eukaryotic expression vector (O'Hare et al., 1981 ). The 
vector contains the mouse MHC class I H-2Kb promo-
tor (Kimura et al., 1986} and was a generaus gift from I. 
Horak, Würzburg (1. Horak, unpublished). This plasmid 
is shown in Fig. 1. pHbel-1 a is a non-expressing ~on­
trol plasmid harboring the bel-1 genein reverse Orienta-
tion with respect to the promoter. 
p5'L TR and p5'L TRinv were the source of all further 
L TR mutants and were generated by excising the Kpn/1 
Narl fragment, spanning the complete 5'L TR, from the 
infectious molecular clone pHSRV (Rethwilm et al., 
1990), treatment with Klenow enzyme, and insertion 
U3 R US 
- TAF +TAF fold 
activation 
+351 1.0 10.1 10 
+313 0.1 61.7 88 
+295 0.3 38.9 129 
+249 0.3 69.1 230 
+195 0.3 86.7 289 
+173 0.3 94.4 314 
+102 0.3 84.3 281 
+35 0.3 92.9 310 
+4 0.3 92.9 310 
-13 0.8 84.9 106 
-79 0.5 2.8 6 
FIG. 2. Positive effect of nested deletions of the R-U5 region on HFV LTR promotor activity. Assay conditions: 50 14g of protein tysate was 
incubated for 60 min. 
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U3 R OS 
- TAF + TAF fold 
activation 
-777/+351 0.9 12.7 14 
-582/+351 0.3 22.5 75 
-501/+351 0,3 43.7 146 
-486/+351 0.3 43.3 145 
-399/+351 0.3 33.3 111 
-261/+351 0.3 11.4 38 
-238/+351 0.3 7.5 25 
-191/+351 0.3 10,5 35 
-159/+351 0.3 8.6 29 
-147/+351 0.3 10.1 34 
-92/+351 0.3 2.5 8 
-33/+351 0.3 0,6 2 
-777/+4 1.0 61.9 6S 
-582/+6 0.8 60.7 61 
-501/+6 0.8 83,3 104 
-486/+6 0.6 74,9 125 
-261/+6 0,6 49.8 83 
-238/+6 0.6 52.1 87 
-159/+4 0.6 50.4 84 
-135/+4 1.2 51,1 48 
-112/+4 1.7 19.8 12 
-107/+4 0,7 10.8 15 
-93/+4 1.0 2.9 3 
-92/+4 l.l 3.0 2 
-84/+4 
- 2.4 10.0 4 
-77/+4 
-
2.2 11.6 5 
-60/+4 2.0 4.8 2 
-51/+4 2.4 .1.1.0 2 
-33/+4 (pTATA) 2.4 5.9 2 
FIG. 3. The BRE in the HFV U3 region is located upstream of nucleotide position -93 relative to the start oftranscription. Nested 5' deletions of 
the HFV L TR were anatyzed to determine the 3' border of the BRE. The dotted verticallines in the L TR represent the three binding sites for the 
transcription factor AP-1. Assay conditions: 50 1'9 protein of lysates from cells transfected with constructs bearing the R·U5 region and 25 #9 
from cells transfected with constructs bearing only U3 sequences was incubated for 60 min. 
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U3 R 05 
- TAF + TAF fold 
activation 
-777/+351 1.0 10.1 10 
-777/+351RV 0.8 11.6 15 
-777/+4 0.3 92.9 310 
-777/+4RV 0.4 89.6 224 
-777/-79 0.5 91.6 183 
-717/-35B 0.3 66.5 222 
-777/-378 0.5 93.0 186 
-777/-442 0.5 38.0 76 
-777/-471 0.4 8.1 20 
-777/-529 0.2 0.1 4 
-7771-567 0.4 O.B 2 
pTATA 0.5 1. 3 2 
FIG. 4. The BRE is located downstream of nucleotide position -4 71. Nested 3' deletions of the U3 region were analyzed to determine the 5' 
border of the BRE. The dotted lines represent the three binding sites for the transcription factor AP-1 . Assay conditions: 50 #19 protein was 
incubated for 60 min. 
into the Smal site of the pUC 19 vector in either orienta-
tion. 
Deletion mutagenesis of R-U5. sequences from the 3' 
end was performed by Bal31 digestion of EcoRIIinear-
ized p5'L TR, Klenow treatment and religation with a 
Bglll linker. BamHI/Bg/11 fragments were excised from 
the resulting plasmids and inserted into the chloram-
phenicol acteyl-transferase (CAT) expression vector 
pOcat-Bg (Rethwilm et af., 1990), resulting in the con-
structs shown in Fig. 2. 
Similarly deletion mutagenesis of U3 sequences 
from the 5' end was carried out by Bal31 digestion of 
EcoRIIinearized p5'L TRinv. p5'cat constructs obtained 
this way are depicted in Fig. 3. For removal of the R-U5 
region in these constructs a Bal31 3' digestion product 
deleting sequences up to base +4 (start of transcrip-
tion is +1} was used, alternatively R-U5 was deleted 
with Sacl which cuts at position +6 and in the pUC 
polylinker. 
To facilitate deletion mutagenesis of the U3 region 
from the 3' end, an EcoRV site was introduced immedi-
ately upstream ofthe TATA box at position -34 relative 
to the start of transcription by in vitro mutagenesis, 
using the oligonucleotide 5'-CTIATATACGATATC-
CATCA TICTI AAAAC-3' (mutated nucleotides are in 
bald face) after Subcloning a Hindiii/Xbal fragment of 
p5'LTR into the m13mp19 vector. The mutated Hindi II! 
Xbal fragmentwas then substituted for the respective 
fragment of p5'cat (-777/+351) and p5'cat (-777/+4) 
leading to p5'cat (-777/+351)RV and p5'cat (-777/ 
+4)RV, respectively. 3' U3 deletions were introduced 
into p5'cat (-777/+4}RV by cutting with EcoRV and 
appropriate restriction enzymes in U3 and religation 
after Klenow enzyme treatment. Alternatively, Hindill 
(position -362) cut plasmid was digested with Bal31 
and religated after EcoRV cleavage so that only the 
truncations in the 5' direction from the Hindill site be-
came effective. Plasmids obtained this way are shown 
in Fig. 4. 
The pTATA (-33/+4) vectorwas created bydeleting 
the U3 region upstream of the TATA box as a Bg/111 
EcoRV fragment from p5'cat (-777/+4)RV and religa· 
tion with a Bg/11 linker. LTR fragments· or chemically 
synthezised oligonucleotides introduced into this vec-
tor are depicted in Figs. 5-8. 
The enhancer-less vector pA10cat (Laimins et al., 
1984) was used to test LTR motifs for enhancer func-
tion in a heterologous (SV40) promoter context. DNA 
fragments of the HFV LTR, or chemically synthesized 
and annealed oligonucleotides, were introduced into 
the Bg/11 site 5' to the CAT gene. These constructs are 
shown in Fig. 9. 
Transfeetions and CAT-assays 
Babyhamster kidney cells (BHK-21) and dog thymus 
Cf2Th fibroblasts were obtained from Dr. Neumann-
Haefelin (Freiburg, Germany) and the ATCC, respec-
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; g U3 fold 
- TAF" + TAF 
act1vat1on 
pTA!l'A -534/-358 
-
1.6 86.5 54 
pTA.'D. -491/-358 
- -
1. 6 86.0 54 
p'l'ATA -436/-358 
- -
1.4 82.3 59 
pTATA -413/-358 
- -
1.4 79.7 57 
pTATA -399/-358 
- -
1.2 59.1 49 
pTA!l'A -397/-358 
- -
1.4 21.5 15 
pTATA -382/-358 
- -
1.4 16.8 12 
p'l'M'A -376/-358 
- -
2.0 12.3 6 
pTATA -372/-JSB 
- -
1.7 13.0 8 
pT.M'A 
-
1.5 7.2 5 
FIG. 5. BREI is located between nuc/eotide positions -413 and -358. Nested 5' deletions ot the -534/-358 sequence of U3 introduced into 
the pTATA (-33/+4) vectorwere assayed to map BREI. The dotted lines represent the AP-1 binding sites. Assay conditions: 50 Ji9 protein were 
incubated for 60 min. 
tively. Both cells are susceptible to HFV infection 
(Rethwilm et al., 1990; and our unpublished Observa-
tion). Cells were kept in MEM supplemented with 
5-1 Oo/o fetal bovine serum, glutamine, and antibiotics. 
Transfeetions of 5 x 105 cens were carried out by the 
calcium phosphate co-precipitation method as de-
scribed (Rethwilm et al., 1 991 ). The transfection cock-
tail contained 5 ll9 of indicator plasmid and 1 ~9 of 
effector plasmid, either pHbel-1s or pHbel-1a. The 
DNA concentration was adjusted to 20 ,ug/ml with her-
ring sperm DNA. Cells were harvested after 48 hr by 
scraping and lysates were prepared as described 
(Rethwilm et al., 1991 ). The protein concentration of 
the lysates was measured with a commercial assay 
(Bio-Rad). The amount of protein assayed and the incu-
bation time were kept constant within a series of tests 
but differed from series to series (as specified in the 
figure legends) to be in the linear range. Lysates were 
analyzed in a total volume of 200 ~-LI 250 mM Tris-HCI, 
pH 8.0 containing 0.5 mM acetyi-CoA (Sigma) and 0.1 
~Ci of [14C]chloramphenicol (Amersham) at 37°. Non-
acetylated chloramphenicol was separated from ace-
tylated forms by ascending thin-layer chromatography 
and the spots were quantitated with a Molecular Dy-
namics Phosphor! mager. Foreach construct 5-6 inde-
pendent transfections with DNA from two preparations 
were performed. Variation of CAT values for a given 
construct was less than 20o/o. 
RESULTS 
Negative effect of R-U5 sequences on HFV gene 
expression 
Previous studies on the role of R-U5 sequences on 
HFV LTR directed gene expression have led to contro-
versial results. While a moderate increase in activity 
has been reported for U5 and R-U5 defeted LTR con-
structs in one study (Rethwilm et al., 1 991 ), no such 
effect was observed by others (Keller et al., 1991 ). For 
SFV-1 and SFV-3 a marked increase in reporter gene 
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AAGCTTTCACATACTCAGTAGCTGTTTCACAATCAACAAAACAATGATGATGTAATCATAAGGAAGTAGTTT 
-361/-291 
AAGCTTTCACATACTCAGTAGCTGTTT OLIGO TJ 
AGCTTTCACATACTCAGTAGCTGTTTCACAATCAA OLIGO SO 
TCACAATCAACAAAACAATGATGATG OLIGO MM 
CAAAACAATGATGATGTAATCATAAGGAAGTAGTTT OLIGO BG 
pT.A!rA 
TAATCATAAGGAAGTAGTTT 
~ 
- TAF 
1.1 
OLIGO HH 
fold 
+TAF 
act1vat1on 
8.3 3 
-361/-291 ~-----{@!: 2.5 83.2 33 
lXBG 3.0 26.9 9 
3xBG 2.9 75.5 26 
lxso 2.9 56.9 20 
SxBB 2.9 13.6 5 
lxTJ 3.2 23.6 7 
lX'rJ 3.2 24.<) 8 
~ 
lxMM 3.1 11.6 4 
3.1 11.3 4 
-384/-345 3.0 18.3 6 
FtG. 6. BRE II is located between nucleotide positions {-361/-291 ). Sequences of the upper strands of the Hindiii/Dral (-361/-291) fragment 
of U3 spanning the BRE II and of chemical\y synthesized oligonucleotides that were used to dissect element II are shown. The arrows above the 
open boxes indicate the orientation of the oligonucleotides with respect to the direction of transcription. The filled boxes represent the Ionger 
DNA fragments introduced into pTATA. Assay conditions: 50 ~ot9 proteinwas incubated for 60 min. 
expression of R-U5 deleted L TRs has been described 
{Mergia et al., 1992: Renne et af., 1993). We therefore 
wanted to analyze the effect of R-U5 on reporter gene 
expression by measuring the CAT activity of LTR mu-
tants with nested deletions introduced from the 3' end 
after co-transfection with pHbel-1 s {Fig. 1 ). As shown 
in Fig. 2, up to 30-fold increase in T AFHFV mediated 
CAT gene expression was obtained with mutants de-
leting U5 (construct + 195) compared to a construct 
that extends into the primer binding site (construct 
+351 ). Further deletions of R sequences did not result 
in higher Ievels of expression. However, it is likely that 
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U3 ] 
!old 
-TM +TAF activatlon 
pTATA 
-
2.1 14.0 5 
pTATA -209/-79 
-
0.8 80.0 100 
pTATA -146/-19 
- -
o.& 88.8 111 
pTATA -133/-'19 
- -
1.1 78.3 71 
pTATA -124/-19 
- -
1.6 88.6 55 
pTATA -111/-79 
--
1.5 53.3 36 
pTATA -93/-79 
--
2.4 35.6 14 
pTATA -86/-'79 
--
2.5 23.9 10 
pTATA -290/-128 
-
1.6 10.1 '7 
Fra. 7. BRE 111 is located between nucleotide positions -124 and -93. Nested 5' deletions of the fragment -209/-79 introduced in the pTATA 
vector were assayed to map BRE 111. Assay conditions: 50 #9 proteinwas incubated for 60 min. 
the assays with further R truncations were beyond the 
linear range in this assay series. lnterestingly, the viral 
cap site and adjacent 5' sequences were not found to 
be required for TAFHFv augmented gene expression 
(construct -13 in Fig. 2). A significant reduction in ac-
tivity was only noted with construct -79 which deletes 
the HFV TATA box. 
Mapping of the BEL-1 responsive region 
To map TAFHFV responsive sequences in the U3 re-
gion of the HFV L TR we first investigated a set of 
nested 5' deletions which are depicted in Fig. 3. An 
increase in activity was observed when the 5' 280 bp of 
U3 were deleted regardless of whether or not the con-
structs contained the R-U5 region. However, this effect 
was more pronounced with constructs bearing R-U5. 
Using the deletion mutants of both construct types, a 
first reduction in activity was found at position -261 
and the secend reduction was observed at position 
-93. These results indicate that the major BEL-1 re-
sponsive region is located in U3 5' of position -93 and 
that there is at least one further element which· may be 
located upstream of position -261 . 
Truncations of U3 from the 3' end were then ana-
lyzed. To facilitate this an EcoRV restriction site was 
introduced by in vitro mutagenesis at position -34 im-
mediately 5' to the TATA box. As shown in Fig. 4, the 
introduction of the EcoRV site does not significantly 
alter the activity of the HFV LTR, either with or without 
R-U5, in response to the transactivator. Using the 3' 
deletion mutants, the 5' border of the BEL-1 response 
region was determined to be located at approximately 
position -471, since sequences extending from -471 
to -777 did not respond to TAFHFV. Theseexperiments 
also revealed two reductions in activity between posi-
tions -378 and -442 and between positions -442 
and -4 71 indicating major responsive sequences 
downstream of positions -442 and -471. 
Taken together, the results obtained with the 5' and 
3' deletion mutants of U3 show that the complete BRE 
is located between positions -93 and -4 71 relative to 
the start of transcription. There is also evidence for 
several target sites of TAFHFV within this element. 
Physical dissection of the BRE 
We next investigated to what extent portians of the 
BRE were able to respond to TAFHFV· To accomplish 
this, HFV U3 fragments were cloned into the pTATA 
vector which essentially bears onfy the core promoter 
sequences between positions -33 and +4. pTATA it-
self, however, is not completely silent and is activated 
approximately two- to sixfold when co-transfected with 
the BEL-1 expression plasmid (Figs. 3-8}. Thus, only 
those fragments that were stimulated significantly 
more than 6 fold were regarded as BEL-1 responsive. 
The first sequence studied for TAFHFV responsive-
ness was the portion upstream of position -358. 
Within this region the HFV LTR bears three recognition 
sequences for the ubiquitous transcription factor AP-1. 
lt had been shown previously that AP-1 exerts a moder-
ate effect on HFV promoter activity and is dependent 
on functionally active AP-1 binding sites. However, this 
effect was found tobe distinct from the action of BEL-1 
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fold 
BRE 
- TAF' + TAF' 
activatlon 
BamHI 
p1'M'A ~I 1.6 9.6 6 
-.... 
-5'11/-358 ~ z.+-AP-1 1.6 72.3 45 
--.... 
-361/-291 ~I II 1.7 31.6 18 
~ 
l.XSO ~~ 1.2 24.4 20 
1.3 56.1 43 
1.6 15.7 10 
LS 9.1 6 
-290/-79 ~ r--------r--- IJI 1.2 6.6 6 
III 1.2 5.4 5 
-107/-34 ~ lt-•---- 1.9 6.5 3 
FtG. 8. Analysis of positional effects of BRE 1-fll on enhancer activity. DNA fragments and oligonucleotides covering BRE 1-111 introduced into 
the BamHI site downstream of the CAT genein the pTATA vector were measured for BEL-1 response. Filled boxes represent Ionger DNA 
fragments and open boxes represent oligonucleotides. The arrows indicate the orientation of the cloned sequences with respect to the CAT 
gene. Assay conditions: 50 ll9 lysate was incubated for 60 min. 
(Maurer et al., 1991 ). When 5' truncations of the -534/ 
-358 fragment (Fig. 5) were analyzed, DNA fragments 
retained inducibility byTAFHFV until truncations passed 
position -413 where the first reduction in activity was 
noticed. A more dramatic decrease in activity was ob-
served between positions -399 and -397 which may 
indicate that a crucial DNA site for BEL-1 actionwas 
affected. Taken togetherthe results from Figs. 4 and 5, 
the BEL-1 target site I was duly identified tobe located 
in the 36 bp region between positions -413 and -378. 
The site therefore resides outside the AP-1 binding 
sites which are located upstream of position -439. We 
also observed that the 5' deletions analyzed in this ex-
periment all gave rise to lower stimulative indices than 
the construct -777/-358 in Fig. 4 that covers the 
same target element. This may be attributed to the 
lower basal activity of the latter. 
The second portion to be studied was defined by the 
restriction sites for Hindill and Oral at positions -361 
and -291, respectively. When this fragment was 
placed in front of the CAT genein the pTATA vector, a 
clear response to TAFHFv was noted (Fig. 6). Because 
of the relatively small size of this element, we at-
tempted to further dissect the BEL-1 target site by us-
ing oligonucleotides that were introduced into the 
pTATA vector (Fig. 6). Oligonucleotide SO spanning 
the 5' half of the Hindlll/Oral iragment was activated 
approximately 20-fold by TAFHFV, but this did not 
achieve the stimulative index of the complete frag-
ment. The activation of the SO element was found to 
be orientation independent with respect to the direc· 
tion ot transcription. Oligonucleotide BG spanning the 
3' half of the Hindiii/Dral fragment did not respond to 
TAFHFV when a single copy was present in the con-
struct. However, three copies of this element gave rise 
to a measurable response, irrespective of its orienta-
tion. This may indicate that the SO and BG sequences 
are only partially able to fulfill the requirements of a 
fold fold 
BRE 
- TAF • TAF - taf + taf 
act1vat1on acti vatlon 
0.6 3.5 6 0.1 l.J 2 
I,II,III 2.5 60.6 24 1.0 21.7 22 
+AP-1 
pA10cat -79/-777 I,II,III 2.3 75.3 JJ" 1.2 29.3 24 +AP-1 
pAlocat -34/-571 I,II,III 1.5 31.3 25 1.3 13.8 11 
+AP-1 
II,III 1.8 53.8 30 1.2 26.8 22 
pA10cat -135/-34 III 0.8 42.1 53 l.O 22.9 23 
pA10cat -107/-34 1.2 31.0 26 0.3 11.5 38 
p&10cat -&t/-34 1.2 12.6 10 0.1 3.6 5 
p&10aat -290/-79 III 0.3 13.0 43 0.5 10.4 21 
111 O.J 20.8 69 0.5 2.9 6 
pA1ocat -361/-2~1 ll 1.7 41.8 25 0.7 18.6 27 
~0cat -291/-361 ll 1.0 51.4 51 0.9 10.1 11 
pA10cat -571/-358 I+AP-1 2.4 54.5 23 0.5 7.9 16 
p&10cat -358/-571 I+AP-1 1.8 '1.1 40 1.2 15.5 13 
pA1ocat -C35/-l58 I 0.8 24.5 30 0.3 2.1 7 
pAlocat -399/-358 o.e 3.8 5 0.4 1.4 4 
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U3 R US 
"NRE" AP-1 
I II 111 
BRE 
FIG. 1 0. Schematic drawing of the HFV L TR showing the cis-regu-
latory elements identitied in this study. "NRE" represents a pro-
posed weak negative regulatory element in the upstream U3 region, 
AP-1 marks the region with the three binding sites for the transcrip-
tion factor AP-1, and BRE l to 111 indicate the three BEL-l transactiva-
tor responsive elements. 
functionally active BEL-1 target site. When Subfrag-
ments of SO and BG (TJ and HH) or an oligonucleotide 
spanning the middle of the Hindiii/Dral fragment and 
overlapping SO and BG (MM) were analyzed, none of 
these was significantly activated over background val-
ues, even when multimerized oligonucleotides were 
tested. ln summary, these results suggest that the 
complete target site II is located within the 71 bp region 
between positions -361 and -291. Ta show that ele-
ments I and II are indeed physically distinct, we also 
tested a DNA fragment that spans the overlap of both 
elements (construct -384/-345 in Fig. 6). Consistent 
with the view of two target sites this elementwas not 
found tobe stimulated by TAFHFV· 
The third portion analyzed was the promoter proxi-
mal element. As shown in Fig. 7 I the region between 
-209 and -79 responded weil to BEL-1. When nested 
5' deletlons of this fragment were tested I CAT activity 
remained high for constructs with truncations up to 
position -124, then gradually declined and ap-
proached values close to background as the deletion 
reached position -93. Tagether with the results 
shown in Fig. 31 target site lll was localized within the 
32 bp region between positions -124/-93. We also 
studied the sequence between targets II and 111 using 
the construct -290/-128 (Fig. 7) which did not re-
spend to T AFHFV, indicating that there are no further 
BEL-1 targets in this region. lnterestingly, the -290/ 
-128 construct also covers the sequence of HFV 
which shows homology to an element in the HIV-1 U3 
region and has been implicated in cross-transactiva-
tion of HIV-1 by HFV BEL-1 (Lee et al., 1992). The irre-
sponsiveness of construct -290/-128 to BEL-1 indi-
cates that the homologaus sequence motif is not suffi-
cient to act as a BEL-1 target. 
To test whether or not positional effects influence 
the activity of the identified BREs, we cloned several 
fragments into the BamHI site of the pTATA vector ap-
proximately 1600 bp downstream of the promoter. The 
results of co-transfections using these constructs with 
pHbel-1 s are shown in Fig. 8. Construct -571/-358 
which coverselementland the three AP-1 sites is acti-
vated to approximately the same extent as the -534/ 
-358 fragment inserted close to the reporter gene into 
the Bg/11 site {Fig. 5). Element II (construct -361/-291) 
is also activated when cloned downstream of the CAT 
gene, however, to a lesser extent compared to the re-
spective fragment inserted into the Bg/11 site (Fig. 6). 
When the oligonucleotides SO and BG (Fig. 8} were 
substituted 1or the complete Hindiii!Dral fragment 
spanning element II, the BG elementwas found not to 
respond to TAFHFV whereas element SO appeared to 
be an active target site for the transactivator. The in-
crease in reporter gene activity of a construct bearing 
multimerized copies of the SO sequence is typical for 
inducible enhancer elements (Seriling et al., 1985). ln 
cantrast to the findings with BRE I and II we found that 
element 111 did not respond significantlyto TAFHFVwhen 
located at some distance from the promoter. 
The BEL-1 targets are conditional enhancer 
elements 
We finally investigated to what extent the BREs are 
active in a heterologous promoter context. HFV LTR 
portions, or oligonucleotides, were inserted into the 
SV40 promoter bearing CAT expression plasmid 
pA10cat that had been used previous\y to identify TAX 
responsive sequences in the L TR of human T-cellleu-
kemia virustype I (HTLV-1) (Paskalis et al., 1986). Andin 
addition to the BHK-21 cells exclusively used in the 
experiments reported above constructs were also ana-
lyzed in the Ct2Th cell line. 
The results of these experiments are summarized in 
Fig. 9. When U3 fragments covering all BREs were an-
alyzed they were found to respond to BEL-1 irrespec-
tive of their orientation to the CA T gene in both cell 
lines tested. Furthermore, all but one individual ele-
ments that were previously found to confer BEL-1 re-
sponsiveness to the HFV promoter were also found to 
be active with the SV40 promoter, although to a lesser 
extent. The -399/-358 construct, partially active in 
the pTATA vector (Fig. 5), showed no responsein the 
pA10cat context. All three BREs were active indepen-
dent of their orientation with respect to the reporter 
gene. However, some cell type differences were no-
ticed. Generally, transactivation was found to be 
FtG. 9. Analysis of the promoter and celltype dependence of BRE 1-111. U3 DNA fragments covering BRE 1-111 were introduced into the Bglll site 
of pA10cat The orientation of the fragments relative to the reporter gene can be deduced from the position of the numbers after each construc' 
which indicate the fragment borders. The dotted lines represent the AP-1 binding sites. Assay conditions: 25 p.g protein of BHK celllysates were 
incubated for 40 min, and 50 Jl9 protein of Cf2Th celllysates was incubated for 60 min. 
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weaker in dog thymus cells, in particular, construct · 
-435/-358 covering element I and construct -79/ 
-290 bearing element 111 in reverse orientation with 
respect to the reporter gene, were barely stimulated. 
DISCUSSION 
We report here a detailed analysis on the BEL-1 re-
sponsive sequences in the LTR of HFV. This was facili-
tated by analyzing L TR fragments in both homologaus 
and heterologous promoter contexts for responsive-
ness to the BEL-1 transactivator. 
The R-U5 region was found to negatively influence 
HFV LTR directed gene expression. The negative regu-
latory function of SFV-1 and SFV-3 R-U5 has been at-
tributed to an extensive secondary structure of the na-
scent R-U5 mRNA (Mergia et al., 1 992; Renne et al., 
1993). Analysis of HFV R-U5 sequences, using the Ge-
netics Computer Group Fold Program (University of 
Wisconsin, Madison, Wl), revealed a secondary struc-
ture with the free energy of -73 kcal/mol (data not 
shown}. The significance of this finding for the ob-
served effect of R-U5 on HFV gene expression remains 
in question until studies using in vitro mutagenized LTR 
constructs, which disrupt the postulated RNA second-
ary structure, have been performed. Furthermore, it is 
so far not clear whether co-transcriptional or post-tran-
scriptional events, as for example the utilization of the 
HFV mRNA, are responsible for the observed negative 
effect of R-U5. However, it is noteworthy that the splice 
donor of HFV has been mapped to position +51 (Mur-
anyi and Flügel, 1991 ). A putative negative effect of 
R-U5 would therefore influence the genomic or gag-pol 
mRNA alone. lmprovement of the transactivation val-
ues obtained with the R-U5 deletion mutants pre-
sented in Fig. 2 seems nottobe the result of splicing 
events using the HFV splice donor at position +51, 
since the constructs extending to positions + 195 
showed similar activation Ieveis as constructs that are 
lacking the splice donor (+4 and +35 in Fig. 2}. 
A second element which exerts a weak negative ef-
fect on HFV L TR directed gene expression was located 
in the upstream U3 region. A similar Observation has 
been described for the upstream U3 region of SFV-3 
(Renne et al., 1 993). A negative regulatory element has 
also been located in the U3 region of HIV-1 (Rosen et 
al., 1985}. However, to what extent the HFV se-
quences constitute a true negative regulatory element 
remains to be determined, for example, by testing its 
effect an the activity of a variety of constitutive pro-
moters. 
Three elements in the HFV LTR were identified that 
were able to respond independently from each otherto 
BEL-1. Element I was mapped to sequences -413/ 
-378 relative to the start of transcription. lt resides 
outside the binding sites for the transcription factor 
AP-1 which has previously been shown to exert a mod-
erate effect on HFV gene expression (Maurer et al., 
1991 ). While element I was found to be active with the 
homologaus as weil as with the SV40 promoter in 
hamster kidney cells, it was only weakly stimulated in 
dog thymus fibroblasts when placed in the heterolo-
gous promoter context. Whether or not this indicates 
any enhancer cell specificity (Serfling et al., 1985) 
might be shown by a closer analysis using additional 
celllines and different promoters. 
Element II was located between positions -361 I 
-291. Because element II responded to TAFHFV, irre-
spective of its position and orientation relative to the 
promoter and irrespective of the kind of promoter used 
and cell type analyzed, it behaves like a typical induc-
ible enhancer (Serfling et al., 1985). When fragments of 
element II were analyzed for enhancer activity (oligonu-
cleotides SO and BG in Fig. 6) they gave rise to a partial 
response that could be restered by multimerization of 
the targets. Further subfragments were found to re-
spend only weakly to BEL-1. The dissection of element 
II into functional partially active fragments may indicate 
that BEL-1-mediated transactivation is a complex 
mechanism which might involve DNA sites with differ-
ent specificities. BREs I and II were found to lay close 
to each other. However, the inactivity of a DNA frag-
ment partially overlapping both elements (-384/-345 
in Fig. 6) is indicative of two separate elements. 
Element 111 was mapped to the positions -124/-93. 
This elementwas also found tobe active in dog thymus 
cells with the heterologous promoter, irrespective of its 
orientation to the reporter gene (Fig. 9). However, it did 
not act weil when placed distant from the promoter 
(Fig. 8). This might reflect the natural situation in the 
HFV LTR, where BRE 111 is located next to the promoter. 
Figure 10 summarizes the organization of the HFV LTR 
deduced from our studies. 
ln a recent study Lee et al. ( 1993) identified five BEL-
1 response elements in the HFV L TR that were located 
at positions -559/-506 (a}, -454/-418 (b), -360/ 
-342 (c), -327/-284 (d), and -116/-89 (e). While our 
mapping experiments are in close agreement with re-
spect to the elements c-e we could not show that frag-
ments covering the region of elements a and b in the 
study of Lee et al. contribute substantially to the BEL-l 
mediated transcriptional activity of the HFV LTR 
The HFV BREs 1-111 do not share sequence homolo-
gies, and to our knowledge, do not show obvious ho-
mologies to known eukaryotic enhancer sequence 
motifs. ln this respect HFV is similar to SFV type 1 and 
3 (Mergia et at.,' 1992; Renne et al., 1993). ln prelimi-
nary experiments we were unable to demonstrate di-
rect binding of a prokaryotically expressed ,8GAUBEL-
1 fusion protein to HFV L TR sequences, although bac-
terially expressed ßGAUJUN protein did bind to its 
target sequence (data not shown). Similar observa-
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tions have been made recently (Venkatesh et al., 
1993). lt is therefore likelythat BEL-1 mediated transac-
tivation makes use oi a novel method to regulate retro-
virus gene expression which might also involve, as yet, 
undiscovered cellular transcription factors. These cel-
lular tactors must be ubiquitous since replication and 
transactivation of HFV have been reported for a wide 
range of cells from different tissues and sp~cies 
(Hooks and Detrick-Hooks, 1981: Rethwilm et al., 
1991; Keller et al., 1991 ). With respect to the likely 
involvement of cellular factors in transactivation by 
BEL-l, HFV is reminiscent of HTLV-t (Marriot et al., 
1989; Fujisawa et al., 1991; Zhao and Giam, 1992; 
Tang-Starksen and Peterlin, 1990). The finding that a 
sequence distinct from the 21 bp repeat can serve as a 
target for TAX (Marriot et al., 1989) isafurther analogy 
between HTLV-1 and the results reported here for the 
disparate elements of the H FV L TR responding to 
BEL-1. 
The requirements for BEL-1-mediated transactiva-
tion have been analyzed at the protein Ievei by using 
mutants ot BEL-1 {Venkatesh et al., 1993; He et al., 
1993). However, the results have been controversially 
interpreted. While Venkatesh et al. (1993) suggested 
the minimal activation domain to be located in the re-
gion of aa positions 56-227, He et al. (1993) mapped 
the activation domain to the 50 c-terminal aa ofthe 300 
aa BEL-1 protein and favored the view of a direct inter-
action of BEL-1 with its target DNA. This conc,usion 
was mainly drawn from the activation of the human 
immunodeficiency virus type 1 L TR by chimeras com-
prising the VP 16 activation domain and c~terminally 
truncated BEL-1. 
Fundamental questions in elucidating the molecular 
mechanism of BEL-l transactivation of its own LTR are 
still open, for example, whether or not BEL-1 interacts 
directly with the target DNAs, or perhaps has DNA 
binding properties itselt. and what additional cellular 
proteins may be involved in BEL-1 transactivation. The 
knowledge of the exact target sites for BEL-1 identified 
in this study will be of use in answering these ques-
tions. 
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